Labs / CDMO: development & manufacturing

IGI
New York, NY, United States · iginnovate.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
IGI is a global, clinical-stage biotechnology company focused on developing innovative biologics in oncology. It is headquartered in New York, NY, with additional centers of innovation in Switzerland and India. The company is advancing multispecific antibody programs for hematological malignancies and solid tumors.
Their website has a general contact form; we send your quote request through it.
What they offer
Multispecific biologics discovery and development
Develops novel first-in-class multispecific biologics for oncology programs from discovery through clinical development.
Protein engineering platform development
Uses its BEAT technology platform to engineer full-length multispecific antibodies with manufacturability in mind.
Clinical-stage oncology program advancement
Advances oncology biologics candidates through clinical-stage development.
Process development
Conducts process development activities at its Switzerland center of innovation.
Manufacturing
Carries out manufacturing activities as part of its Switzerland-based operations.
What they work on
- Modalities
- Antibody, Bispecific
- Therapeutic areas
- oncology, hematological malignancies, solid tumors, multiple myeloma
- Sites
- New York, USA · La Chaux-de-Fonds, Switzerland · Neuchâtel, Switzerland · Lausanne, Switzerland
- Team
- Approximately 100 employees
- Serves
- global
Similar labs. 3C Therapeutics, Adragos Pharma, AGC Biologics, Alphalyse
Found in a contract services directory. Listing built from iginnovate.com. Work here? Claim this listing.